FeesSafety
Pluang+

Metallus Q3 sales rise 10% YoY to $337.2M; net income jumps to $23.8M, boosted by aerospace & defense growth.

Company Fundamentals
02 Nov 2026, 23:10 WIB
PRNewsWire
View Source
Bullish
Metallus Q3 sales rise 10% YoY to $337.2M; net income jumps to $23.8M, boosted by aerospace & defense growth.

Metallus reported third-quarter 2026 net sales of $337.2 million, up 10% year over year, with net income rising to $23.8 million from $8.1 million in Q3 2025. Adjusted EBITDA increased 19% sequentially and annually, driven by strong demand in aerospace & defense, including a new $125 million U.S. Defense Logistics Agency contract. The company plans a CEO transition and anticipates lower Q4 EBITDA due to seasonal factors and maintenance shutdowns but expects profitable growth into 2027.

Metallus' third-quarter 2026 results provide context for market watchers. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Nov 03, 2026 01:51 WIB: Among 83 priced US stocks, 68 rose and 14 fell today. Notable movers included HMY at USD 15.25 with a 5.54% increase and 100% buy order activity, USAR at USD 9.14 down 4.99% with 72% sell orders, and PPG at USD 125.03 up 4.61%.

More News

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
1 hour ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
3 hours ago
FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

FDA halts Bright Minds' epilepsy trial over toxicity concerns, triggering stock selloff and investor investigation

The FDA placed Bright Minds Biosciences' planned Phase 2 epilepsy trial for BMB-101 on partial clinical hold due to toxicity findings in mice and insufficient pharmacokinetic and juvenile-toxicity data. This action caused a sharp decline in the compa...

Market News
Bearish
5 hours ago
NVIDIA releases Cosmos recipes for advanced vehicle, robot, and surgical simulations using AI models.

NVIDIA releases Cosmos recipes for advanced vehicle, robot, and surgical simulations using AI models.

NVIDIA has published detailed implementation recipes for its Cosmos world models, enabling developers to create simulations for vehicles, robots, and surgical procedures. These recipes guide model adaptation, testing, and GPU deployment, supporting v...

Protocol Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App